Bank Of New York Mellon Corp Alpine Immune Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$17.75 - $41.6 $3.97 Million - $9.3 Million	223,591 Added 218.45%	325,943 $12.9 Billion
Q4 2023 Jan 29, 2024	BUY	$8.54 - $20.22 $874,086 - $2.07 Million	102,352 New	102,352 $1.95 Billion
Q1 2023 May 09, 2023	BUY	$7.0 - $8.75 $502,642 - $628,302	71,806 New	71,806 $554 Million
Q4 2022 Feb 14, 2023	BUY	$5.45 - $7.35 $455,570 - $614,393	83,591 New	83,591 $614,000
Q3 2022 Nov 14, 2022	BUY	$6.89 - $9.39 $40,830 - $55,645	5,926 Added 10.12%	64,480 $464,000
Q2 2022 Aug 15, 2022	BUY	$6.71 - $9.52 $63,067 - $89,478	9,399 Added 19.12%	58,554 $499,000
Q1 2022 May 11, 2022	SELL	$6.41 - $13.89 $16,601 - $35,975	-2,590 Reduced 5.01%	49,155 $441,000
Q4 2021 Feb 11, 2022	BUY	$10.41 - $13.95 $12,564 - $16,837	1,207 Added 2.39%	51,745 $716,000
Q3 2021 Nov 12, 2021	BUY	$8.19 - $11.31 $71,056 - $98,125	8,676 Added 20.73%	50,538 $539,000
Q2 2021 Aug 11, 2021	BUY	$8.81 - $15.03 $168,958 - $288,245	19,178 Added 84.54%	41,862 $376,000
Q1 2021 May 13, 2021	SELL	$10.02 - $13.92 $7,434 - $10,328	-742 Reduced 3.17%	22,684 $240,000
Q4 2020 Feb 09, 2021	BUY	$7.42 - $15.96 $89,692 - $192,924	12,088 Added 106.61%	23,426 $295,000
Q3 2020 Nov 12, 2020	BUY	$7.15 - $11.5 $81,066 - $130,387	11,338 New	11,338 $99,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.